OSAKA -- Japan's Kyoto University has begun sharing its reserve of cells reprogrammed to an embryonic state in an effort to bring regenerative medicine closer to reality.
The university has provided induced pluripotent stem (iPS) cells to Keio University, Osaka University, the government-affiliated Riken institute and other institutions. The cells in the stockpile have been deemed to have a low risk of being rejected when transplanted into patients' bodies.
By continuing to browse this website, you accept cookies which are used for several reasons such as personalizing content/ads and analyzing how this website is used. Please review our
to learn how you can update your cookie settings.